BioSpace News Archive

Biotech Bay

What Do Life Sciences Professionals Value In Employers?

The opportunity to do interesting and meaningful work continues to be more valuable than money, according to more than 2,700 life science professionals who took BioSpace’s 2019 Ideal Employer survey.

October 1, 2019
·
2 min read
·
Editorial Staff
Policy

Some Opioid Drugmakers Could Use Purdue’s Bankruptcy As a Way to Avoid Litigation

Following Purdue Pharma’s Chapter 11 filing last month, other opioid makers are exploring ways to settle their own litigation problems by participating in the OxyContin drugmaker’s bankruptcy proceedings.

October 1, 2019
·
2 min read
·
Alex Keown
Three Retail Pharmacies Suspend Sales of Sanofi’s Zantac

In the wake of the discovery that some Zantac products may contain a carcinogen contaminant due to the manufacturing process, three major drug store retailers in the United States have removed the antacid product from the shelves.

October 1, 2019
·
2 min read
·
Alex Keown
Career Advice

Making the Most of Working with Recruiters

The tips that follow will help you make the most of your relationship with recruiters, also known as headhunters and search firms.

October 1, 2019
·
4 min read
·
Katharine Hansen, PhD
Business

Insilico and Janssen take another step towards predictive biomanufacturing: Digital Twins allow for accelerated timelines in cell line development for biologics production

Insilico Biotechnology AG and the Janssen Pharmaceutical Companies of Johnson & Johnson announced an agreement to apply Insilico’s predictive Digital Twins for the early selection of high-performing cells to further boost efficiency and throughput of their cell line development workflow.

October 1, 2019
·
3 min read
Business

Eisai and Nichi-Iko Enter into Collaboration Agreement for Generic Pharmaceutical Business in China

Eisai Co., Ltd. and Nichi-Iko Pharmaceutical have entered into a comprehensive collaboration agreement for the generic pharmaceutical business in China.

October 1, 2019
·
2 min read
Business

Creoptix Closes Successful Series C Financing Round to Support Further Growth

Creoptix AG announced that is has raised CHF 8 million in the first closing as part of a Series C financing round.

October 1, 2019
·
3 min read
Business

Motif Bio Reports Half-Year 2019 Financial Results, Operational Progress and Proposed Initiatives

Motif Bio plc announced unaudited financial results for the half year ended June 30, 2019 and reported on its progress year to date.

October 1, 2019
·
5 min read
Drug Development

Data from Agios’ Phase 3 ClarIDHy Trial of TIBSOVO® Demonstrates Significant Improvement in Progression Free Survival (PFS) Compared to Placebo in Previously Treated IDH1 Mutant Cholangiocarcinoma Patients

TIBSOVO® Reduced the Risk of Disease Progression or Death by 63% (HR=0.37, p<0.001); Median PFS for Patients Randomized to TIBSOVO® was 2.7 months Compared to 1.4 Months with Placebo

October 1, 2019
·
13 min read